| EMA number | EMEA/H/C/000164 |
| ATC code | J05AE04 |
| Authorisation | 22 January 1998 |
| Withdrawn | 23 January 2013 |
| Revision | 25 |
Viracept is indicated in antiretroviral combination treatment of human-immunodeficiency-virus (HIV-1)-infected adults, adolescents and children of three years of age and older. In protease-inhibitor (PI)-experienced patients, the choice of nelfinavir should be based on individual viral resistance testing and treatment history.